Jeremy Grantham’s GMO Capital Portfolio: Q2 2024 Insights
Friday, 23 August 2024, 02:51
Latest Insights on GMO Capital Portfolio
Tracking Jeremy Grantham’s GMO Capital Portfolio provides valuable insights into significant changes during Q2 2024. The latest 13F filing reveals new positions in Thermo Fisher Scientific and increased holdings in Permian Resources.
Key Updates
- New Stake in Thermo Fisher Scientific
- Enhanced Investment in Permian Resources
These moves reflect Grantham’s strategic outlook on the market, indicating a focus on sectors poised for growth.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.